Leukemia

Myeloid and Monocytic LeukemiaPhase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered in Combination With Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients With Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia
Other HematopoieticA Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat (GRN163L) Versus Best Available Therapy (BAT) in Patients with Intermediate-2 or High-risk Myelofibrosis (MF) Relapsed / Refractory (R/R) to Janus Kinase (JAK) Inhibitor
Myeloid and Monocytic LeukemiaPhase II Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma
Myeloid and Monocytic LeukemiaA Randomized Phase II Study of Venetoclax and HMA-Based Therapies for the Treatment of Older and Unfit Adults With Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML): A MyeloMATCH Treatment TrialPrincipal Investigator: Jan Philipp Bewersdorf
Myeloid and Monocytic LeukemiaMYELOMATCH: A Screening Study to Assign People with Myeloid Cancer to a Treatment Study or Standard of Care Treatment within myeloMATCH (MyeloMATCH Screening Trial)Principal Investigator: Jan Philipp Bewersdorf